Asset

Total 158, page 7/8

No. Organization Therapeutic Area Product Type Title
38 University of Illinois at Chicago Immunology Protein OX40L-Jagged-1-Fc, for the In Vivo Expansion of Treg Cells
37 University of California, San Francisco Oncology Antibody Novel Tumor Selective Internalizing Antiboies
36 University of California, San Francisco Cardiovascular disease Small molecule Covalent Activators Of K2p Channels
35 University of California, San Diego Oncology, Infectious disease Small molecule Small Molecule, TLR-4 Ligands as Immonomodulators
34 University of California, San Diego Oncology Vaccine Encapsulation Method of Adenoviral Vectors in Liposomes
33 University of California, San Diego Inflammatory disease Small molecule Identification of Novel NLRP3 Inflammasome Inhibitors
32 University of California, San Diego Oncology Cell therapy Macrophage Programming for Immunotherapy
31 University of California, San Diego Oncology Small molecule Novel Cyclic Dinucleotide Analogues as STING Agonists
30 The Ohio State University Oncology, Hematology Small molecule HOSU-3, DHODH Inhibitor for Acute Myeloid Leukemia
29 The Ohio State University Oncology Small molecule AHR Inhibitor for Hematological Malignancies
28 The Ohio State University Oncology Small molecule Mps1 Kinase Inhibitors As Mitotic Regulator for Cancer Therapy
27 The Ohio State University Hematology Small molecule DHODH Inhibitors for Treatment of Hematological Malignancies
26 The Ohio State University Oncology Vaccine Activated B cells as Therapeutic Cancer Vaccine Platform
25 The Ohio State University Oncology Small molecule Orally Bioavailable and Brain Penetrant Mps1/TTK inhibitors as cancer therapeutics
24 The Ohio State University Oncology Small molecule STAT3 Inhibitors and Their Anti-Cancer Usage
23 The Ohio State University Immunology, Oncology Antibody Improving Immunotherapy with mRNA Delivery
22 Stanford University Genetic disorders Gene therapy S06-098: Novel AAV capsids with new transduction and nonimmune properties
21 Stanford University Immunology, Oncology Cell therapy MicroRNA Expression in Dendritic Cells for Immune Regulation
20 Stanford University Oncology Antibody Methods to Treat Malignant Pediatric Brain Tumors Using Anti-CD47 Agents
19 Stanford University Ophthalmology Gene therapy miR-494 inhibitor, for the treatment of retinal disease

TOP